As of 2025-05-13, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 14.71 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.04 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 383.7%.
The range of the Relative Valuation is 11.32 - 23.59 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 38.7x | 24.9x |
| Forward P/E multiples | 23.4x - 45.8x | 29.4x |
| Fair Price | 11.32 - 23.59 | 14.71 |
| Upside | 272.3% - 675.8% | 383.7% |
| Date | P/E |
| 2025-05-12 | 4.98 |
| 2025-05-09 | 4.77 |
| 2025-05-08 | 5.03 |
| 2025-05-07 | 4.90 |
| 2025-05-06 | 4.88 |
| 2025-05-05 | 5.03 |
| 2025-05-02 | 5.26 |
| 2025-05-01 | 5.05 |
| 2025-04-30 | 5.21 |
| 2025-04-29 | 4.98 |
| 2025-04-28 | 4.88 |
| 2025-04-25 | 4.92 |
| 2025-04-24 | 4.93 |
| 2025-04-23 | 4.97 |
| 2025-04-22 | 4.93 |
| 2025-04-21 | 4.69 |
| 2025-04-17 | 4.69 |
| 2025-04-16 | 4.72 |
| 2025-04-15 | 4.85 |
| 2025-04-14 | 4.80 |
| 2025-04-11 | 4.62 |
| 2025-04-10 | 4.49 |
| 2025-04-09 | 4.77 |
| 2025-04-08 | 4.74 |
| 2025-04-07 | 4.64 |
| 2025-04-04 | 4.75 |
| 2025-04-03 | 4.79 |
| 2025-04-02 | 4.93 |
| 2025-04-01 | 4.80 |
| 2025-03-31 | 4.85 |
| 2025-03-28 | 5.15 |
| 2025-03-27 | 5.16 |
| 2025-03-26 | 5.13 |
| 2025-03-25 | 5.33 |
| 2025-03-24 | 5.69 |
| 2025-03-21 | 5.75 |
| 2025-03-20 | 5.59 |
| 2025-03-19 | 5.66 |
| 2025-03-18 | 5.47 |
| 2025-03-17 | 5.31 |
| 2025-03-14 | 5.44 |
| 2025-03-13 | 5.47 |
| 2025-03-12 | 5.77 |
| 2025-03-11 | 5.56 |
| 2025-03-10 | 5.61 |
| 2025-03-07 | 5.75 |
| 2025-03-06 | 5.93 |
| 2025-03-05 | 5.80 |
| 2025-03-04 | 5.56 |
| 2025-03-03 | 5.49 |